This work is licensed under the Creative Commons Attribution 4.0 International License.
Almyroudi M, Dimopoulos G, Halvatsiotis P. The role of diabetes mellitus and obesity in COVID 19 patients. Pneumonia. 2020;33(3):114-116.AlmyroudiMDimopoulosGHalvatsiotisPThe role of diabetes mellitus and obesity in COVID 19 patients2020333114116Search in Google Scholar
Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859–65.SpyropoulosACLevyJHAgenoWet alScientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19202018818596510.1111/jth.14929Search in Google Scholar
Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in Hospitalized Patients with COVID-19 in a New York City Health System. JAMA. 2020.BilalogluSAphinyanaphongsYJonesSet alThrombosis in Hospitalized Patients with COVID-19 in a New York City Health System202010.1001/jama.2020.13372Search in Google Scholar
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.HuangCWangYLiXet alClinical features of patients infected with 2019 novel coronavirus in Wuhan, China20203951022349750610.1016/S0140-6736(20)30183-5Search in Google Scholar
Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72–81.BarnesGDBurnettAAllenAet alThromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum2020501728110.1007/s11239-020-02138-zSearch in Google Scholar
Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 February 28;382(18):1708–20. Available from: https://doi.org/10.1056/NEJMoa2002032GuanWNiZHuYet alClinical Characteristics of Coronavirus Disease 2019 in China2020February 2838218170820Available fromhttps://doi.org/10.1056/NEJMoa200203210.1056/NEJMoa2002032Search in Google Scholar
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.ZhouFYuTDuRet alClinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study20203951022910546210.1016/S0140-6736(20)30566-3Search in Google Scholar
Spanakis M, Zoumpoulakis M, Patelarou A, et al. COVID-19 epidemic: Comparison of three European countries with different outcome using Gompertz function method. Pneumonia. 2020;33(2):1-6.SpanakisMZoumpoulakisMPatelarouAet alCOVID-19 epidemic: Comparison of three European countries with different outcome using Gompertz function method202033216Search in Google Scholar
Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Vol. 20, Current Opinion in Hematology. 2013. p. 437–44.BlokhinIOLentzSR2013p437–4410.1097/MOH.0b013e3283634443444563323817170Search in Google Scholar
Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–64.GargSKimLWhitakerMet alHospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020202069154586410.15585/mmwr.mm6915e3775506332298251Search in Google Scholar
Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844– 7.TangNLiDWangXet alAbnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia2020184844–710.1111/jth.14768716650932073213Search in Google Scholar
Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738–42.PanigadaMBottinoNTagliabuePet alHypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis202018717384210.1111/jth.1485032302438Search in Google Scholar
Ikesaka R, Delluc A, Le Gal G, et al. Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis. Thromb Res. 2014;133(4):682–7.IkesakaRDellucALe GalGet alEfficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis20141334682710.1016/j.thromres.2014.01.02124508449Search in Google Scholar
Marietta M, Ageno W, Artoni A, et al. COVID-19 and haemostasis: A position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020;18(3):167–9.MariettaMAgenoWArtoniAet alCOVID-19 and haemostasis: A position paper from Italian Society on Thrombosis and Haemostasis (SISET)20201831679Search in Google Scholar
Riker RR, May TL, Fraser GL, et al. Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome. Res Pract Thromb Haemost. 2020;4(5):936–41.RikerRRMayTLFraserGLet alHeparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome2020459364110.1002/rth2.12390727672632685905Search in Google Scholar
Schindewolf M, Steindl J, Beyer-Westendorf J, et al. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia. J Am Coll Cardiol. 2017;70(21):2636–48.SchindewolfMSteindlJBeyer-WestendorfJet alUse of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia2017702126364810.1016/j.jacc.2017.09.109929169470Search in Google Scholar
Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020.Al-SamkariHKarpLeaf RSDzikWHet alCOVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection202010.1182/blood.2020006520737845732492712Search in Google Scholar
McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circulation Research. 2020. p. 571–87.McFadyenJDStevensHPeterKThe Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications2020p571–8710.1161/CIRCRESAHA.120.317447738687532586214Search in Google Scholar
Manne BK, Denorme F, Middleton EA, et al. Platelet Gene Expression and Function in COVID-19 Patients. Blood. 2020.ManneBKDenormeFMiddletonEAet alPlatelet Gene Expression and Function in COVID-19 Patients202010.1182/blood.2020007214748343032573711Search in Google Scholar